10X Genomics, Inc. (TXG)
69.80
-2.59
(-3.58%)
USD |
NASDAQ |
Oct 16, 13:31
10X Genomics SG&A Expense (TTM) : 297.01M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 297.01M |
| March 31, 2026 | 292.78M |
| December 31, 2025 | 316.13M |
| September 30, 2025 | 333.34M |
| June 30, 2025 | 339.69M |
| March 31, 2025 | 348.30M |
| December 31, 2024 | 344.34M |
| September 30, 2024 | 336.64M |
| June 30, 2024 | 337.35M |
| March 31, 2024 | 345.82M |
| December 31, 2023 | 343.33M |
| September 30, 2023 | 336.09M |
| June 30, 2023 | 327.08M |
| March 31, 2023 | 314.90M |
| December 31, 2022 | 298.30M |
| September 30, 2022 | 289.29M |
| June 30, 2022 | 277.97M |
| March 31, 2022 | 267.33M |
| December 31, 2021 | 257.56M |
| Date | Value |
|---|---|
| September 30, 2021 | 243.66M |
| June 30, 2021 | 233.13M |
| March 31, 2021 | 208.84M |
| December 31, 2020 | 202.33M |
| September 30, 2020 | 185.11M |
| June 30, 2020 | 166.17M |
| March 31, 2020 | 154.33M |
| December 31, 2019 | 130.83M |
| September 30, 2019 | 118.98M |
| June 30, 2019 | 105.48M |
| March 31, 2019 | 94.11M |
| December 31, 2018 | 87.94M |
| September 30, 2018 | 77.38M |
| June 30, 2018 | 70.56M |
| March 31, 2018 | 58.54M |
| December 31, 2017 | 46.74M |
| September 30, 2017 | 30.39M |
| June 30, 2017 | 18.09M |
| March 31, 2017 | 8.92M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Tempus AI, Inc. | 834.84M |
| Personalis, Inc. | 67.03M |
| Intellia Therapeutics, Inc. | 136.25M |
| Alamar Biosciences, Inc. (California) | 31.22M |